Genomics

Dataset Information

0

Netherlands Cancer Institute - Breast Cancer Neoadjuvant chemotherapy biomarker studies

ABSTRACT: Data Access Committee EGAC00001002452

PROVIDER: EGAC00001002452 | EGA |

REPOSITORIES: EGA

Json Xml

Similar Datasets

Unknown FZR1 as a novel biomarker for breast cancer neoadjuvant chemotherapy prediction.
| S-EPMC7519164 | biostudies-literature
Unknown Biomarker Alteration after Neoadjuvant Endocrine Therapy or Chemotherapy in Estrogen Receptor-Positive Breast Cancer.
| S-EPMC9866043 | biostudies-literature
Unknown Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?
| S-EPMC6910196 | biostudies-literature
Unknown FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer.
| S-EPMC7684949 | biostudies-literature
Unknown A review of studies on omitting surgery after neoadjuvant chemotherapy in breast cancer.
| S-EPMC9442028 | biostudies-literature
Unknown ITPKC as a Prognostic and Predictive Biomarker of Neoadjuvant Chemotherapy for Triple Negative Breast Cancer.
| S-EPMC7601042 | biostudies-literature
Unknown A 3-gene biomarker signature to predict response to taxane-based neoadjuvant chemotherapy in breast cancer.
| S-EPMC7083332 | biostudies-literature
Unknown Comprehensive evaluation of the relationship between biomarker profiles and neoadjuvant chemotherapy outcomes for breast cancer patients.
| S-EPMC10953119 | biostudies-literature
Genomics NKI (Netherlands Cancer Institute)
| EGAC00001001648 | EGA
Unknown Neoadjuvant Chemotherapy Considerations in Triple-Negative Breast Cancer.
| S-EPMC5865448 | biostudies-literature